Carles Cantó

10PUBLICATIONS
54CO-AUTHORS
Nutrigenomics and personalised nutritionCellular nervous systemMetabolic medicineProteomics and intermolecular interactions (excl. medical proteomics)Molecular and organic electronics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 26, 2026
Therapeutic potential of dihydronicotinamide riboside (NRH) on obesity and glucose intolerance in mice.

Marie Rumpler, Guido van Mierlo, Kasper T Vinten

|Oct 14, 2025
NAD<sup>+</sup> precursor supplementation in human ageing: clinical evidence and challenges.

Kasper T Vinten, Maria M Trętowicz, Evrim Coskun

|Sep 09, 2025
Emerging strategies, applications and challenges of targeting NAD<sup>+</sup> in the clinic.

Jianying Zhang, He-Ling Wang, Sofie Lautrup

|Mar 20, 2024
Trigonelline is an NAD<sup>+</sup> precursor that improves muscle function during ageing and is reduced in human sarcopenia.

Mathieu Membrez, Eugenia Migliavacca, Stefan Christen

|Aug 02, 2022
Balancing NAD<sup>+</sup> deficits with nicotinamide riboside: therapeutic possibilities and limitations.

Angelique Cercillieux, Eleonora Ciarlo, Carles Canto

|Sep 22, 2019
Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage.

Audrey Sambeat, Joanna Ratajczak, Magali Joffraud

Pageof 2